Research Article

Hepatic Arterial Therapy with Drug-Eluting Beads in the Management of Metastatic Bronchogenic Carcinoma to the Liver: A Multi-Institutional Registry

Table 1

Clinical characteristics in 13 lung metastatic patients treated with LC beads.

Characteristics 𝑁 = 1 3

Age (years) (median, range)68 (43–72)
Gender
 Male7 (54%)
 Female6 (46%)
Past medical history
 Cardiac3 (23%)
 Vascular2 (15%)
 Pulmonary7 (54%)
 Diabetes3 (23%)
 Insulin1 (33%)
 NonInsulin2 (67%)
 Alcohol2 (15%)
 Tobacco9 (69%)
 Median packs60 (40–300)
 Hypertension8 (62%)
 Prior cholecystectomy4 (31%)
Karnofsky performance scale90% (70–100)
Extent of liver lesions
 Distinct number11 (85%)
 Numerous2 (15%)
Liver involvement
 <25%6 (46%)
 26–50%6 (46%)
 51–75%1 (8%)
Number liver tumors (median, range)4 (1–20)
 118%
 29%
 ≥373%
Sum of target lesion(s) size (median, range)12.7 cm (2.5–21.8)
Lesion location
 Seg 2–41 (8%)
 Seg 4–83 (23%)
 Seg 5–82 (15%)
Other7 (54%)